Nita Radhakrishnan
YOU?
Author Swipe
View article: Diffuse Pulmonary Lesions Due to Invasive Fungal Infection in an Immune-capable Male: A Case Report
Diffuse Pulmonary Lesions Due to Invasive Fungal Infection in an Immune-capable Male: A Case Report Open
Introduction: Invasive fungal pulmonary infection is a fungal illness caused by many species of fungi, including Aspergillus, generally presenting as life-threatening hazards to people with compromised immune systems. Although instances in…
View article: Barriers to cascade screening and prenatal testing in families with genetic haematological diseases
Barriers to cascade screening and prenatal testing in families with genetic haematological diseases Open
Introduction Cascade screening to identify at-risk relatives of patients with genetic conditions is a strong intervention to reducing the burden of genetic disorders. Even then, we often observe more than one child with same genetic hemato…
View article: Comparative Analysis of the Cost of Thalassemia Screening Vs Treatment in Different Healthcare Sectors in Delhi National Capital Region
Comparative Analysis of the Cost of Thalassemia Screening Vs Treatment in Different Healthcare Sectors in Delhi National Capital Region Open
Background: Thalassemia is a single gene disorder that is passed on from parents to children. According to the World Health Organization, the carrier rate of thalassemia in is between 3- 5%. Treatment and management of a thalassemia major …
View article: Conceptualization and Development of Quality of Life Scale for PWH Living in India
Conceptualization and Development of Quality of Life Scale for PWH Living in India Open
There is significant prevalence of haemophilia in India, with second largest number of persons with haemophilia A. Research in India includes diagnostic studies, complications and co-morbidities, prenatal diagnosis, inhibitor development, …
View article: Freedom From Bleeds With Low-Dose Emicizumab Prophylaxis in Inhibitor-Positive Hemophilia A
Freedom From Bleeds With Low-Dose Emicizumab Prophylaxis in Inhibitor-Positive Hemophilia A Open
Emicizumab prophylaxis even in lower doses is effective in preventing bleeds and improving joint outcome in HAI with pre-existing high bleed rate and arthropathy. This opens up an avenue for providing equity in healthcare delivery for HAI …
View article: A Comparative Analysis of the Bleeding Profile and Quality of Life Among Women With Hemophilia Genotype Compared to Other Bleeding Disorders
A Comparative Analysis of the Bleeding Profile and Quality of Life Among Women With Hemophilia Genotype Compared to Other Bleeding Disorders Open
Introduction Women with bleeding disorders continue to be underdiagnosed as well as undertreated. Women with bleeding disorders include those with genotype for hemophilia (traditionally named hemophilia carriers), von Willebrand disease (V…
View article: Universal Health Care for Childhood Cancer in India: Challenges and Solutions for Implementation
Universal Health Care for Childhood Cancer in India: Challenges and Solutions for Implementation Open
Introduction: The World Health Organization has declared a Global Initiative for Childhood Cancer which aims at achieving a cure rate of atleast 60% globally. To achieve this significant planning and policy making would be needed in most L…
View article: Experience of tertiary prophylaxis with extended half-life factor prophylaxis in India
Experience of tertiary prophylaxis with extended half-life factor prophylaxis in India Open
Introduction: The real-world experience on treatment and outcome of hemophilics with extended half-life products is scarce due to the rarity of the disease and poor access to newer treatment modalities. Aim: To analyze the response of pati…
View article: Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab
Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab Open
[This corrects the article DOI: 10.7759/cureus.58941.].
View article: Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab
Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab Open
Hemophilia A (HA) is a genetic disorder of hemostasis associated with a deficiency or reduced activity of clotting factor VIII (FVIII). This disorder remains unacceptably underdiagnosed in India. Early diagnosis and appropriate management …
View article: Assessing the need for home-based end-of-life palliative care in pediatric cancer care
Assessing the need for home-based end-of-life palliative care in pediatric cancer care Open
Background: Palliative care is underrepresented in our community at large. End-of-life care is offered mainly in palliative care hospices or hospitals worldwide. As access to such a facility is often sparse, and since many of them are loca…
View article: Managing childhood acute lymphoblastic leukemia in a child with Emery-Dreifuss muscular dystrophy
Managing childhood acute lymphoblastic leukemia in a child with Emery-Dreifuss muscular dystrophy Open
Genetics is increasingly being integrated into clinical oncology practice. It is necessary for risk stratification of disease, for prognostication, for recognition of underlying predisposition, and for recognition of potential toxicity and…
View article: Managing childhood acute lymphoblastic leukemia in a child with Emery-Dreifuss muscular dystrophy
Managing childhood acute lymphoblastic leukemia in a child with Emery-Dreifuss muscular dystrophy Open
Genetics is increasingly being integrated into clinical oncology practice. It is necessary for risk stratification of disease, for prognostication, for recognition of underlying predisposition, and for recognition of potential toxicity and…